OMRON Healthcare introduced home blood pressure monitors with built-in AI-powered detection of atrial fibrillation. In a medical device first, OMRON blood pressure monitors which feature the company's new novel machine learning IntelliSense™ AFib algorithm will automatically check for AFib during every blood pressure measurement and can provide early detection for a high stroke and heart failure risk.

"OMRON Healthcare is evolving the blood pressure monitoring experience by making AFib screening an integral part of every measurement. AFib is a serious condition that is widely undiagnosed. With Intellisense™ AFib, we are working to help anyone who uses our blood pressure monitors detect this condition earlier so they can reduce the associated stroke, heart failure and dementia risks," said OMRON Healthcare US Managing Director Alice Koehler.

OMRON blood pressure monitors with Intellisense™ AFib are compatible with the OMRON Connect app and clinical accurate.

"Our blood pressure monitors with Intellisense™ AFib automatically screen for atrial fibrillation with every single measurement," said Koehler. "With this breakthrough AFib detection, OMRON is setting a new high standard for the blood pressure monitoring experience."

AFib is the most common type of heart arrythmia3. Left untreated, the condition increases risk of stroke, heart failure, myocardial infarction, chronic kidney disease, and dementia4.

AFib risk factors accelerate over age 40 and include high blood pressure, obesity, diabetes, smoking, heavy use of alcohol, and sleep apnea5.

Medical experts say AFib has become a health epidemic6. A study published in the September 2024 Journal of the American College of Cardiology7 found that AFib is three times more prevalent than previously estimated. The American Stroke Association estimates that millions of Americans with AFib are undiagnosed8 and many may not experience symptoms9.

OMRON IntelliSense™ AFib incorporates over 300 mathematical indices into a machine learning algorithm that analyzes the Pressure Pulse Wave generated as the blood pressure monitor cuff inflates. A clinical study published in the October 2024 Heart Rhythm Journal10 found that OMRON blood pressure monitors with Intellisense™ AFib can detect disturbances specific to AFib with remarkable accuracy.

The FDA granted OMRON Healthcare medical-device authorization for Intellisense™ AFib via the agency's De Novo classification, a regulatory pathway for first-of-their-kind innovations.

With the launch of blood pressure monitors with Intellisense™ AFib, OMRON introduced an AFib education hub that explains the condition, its risk factors, and common symptoms. OMRON's AFib education hub provides details on how Intellisense™ AFib works and how OMRON developed the innovation as part of its Going for Zero mission.

AFib education extends to the OMRON Connect app, which syncs with every Intellisense™ AFib blood pressure monitor via Bluetooth to iOS® and Android® devices. OMRON Connect charts user readings by the day, week, month and year. The app analyzes a user's trends and habits, presents insights to explain data, and provides daily reminders and progress reports. With OMRON Connect, a user can send heart health readings to a doctor.

"Research shows ninety percent of heart attacks and strokes are preventable13. By evolving the blood pressure monitoring experience with Intellisense™ AFib, OMRON is providing unprecedented at-home access to technologies that can make a world of difference in heart health," said Koehler.